Zynex, Inc. (ZYXI)

Market Cap	64.11M
Revenue (ttm)	172.40M
Net Income (ttm)	-7.41M
Shares Out	30.24M
EPS (ttm)	-0.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,183
Open	2.110
Previous Close	2.080
Day's Range	2.090 - 2.180
52-Week Range	1.660 - 11.150
Beta	0.70
Analysts	Buy
Price Target	6.00 (+183.02%)
Earnings Date	Apr 29, 2025

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI
• Website: https://www.zynex.com

Financial Performance

In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.

Analyst Forecast

According to 3 analysts, the average rating for ZYXI stock is "Buy." The 12-month stock price forecast is $6.0, which is an increase of 183.02% from the latest price.

Price Target

$6.0

(183.02% upside)

Analyst Consensus: Buy